Effects of coenzyme q10 supplementation on serum lipoproteins, plasma fibrinogen, and blood pressure in patients with hyperlipidemia and myocardial infarction

المؤلفون المشاركون

Zarrati, Mitra
Shidfar, Farzad
Muhsini, Muna
Vafa, Muhammad Riza
Hajimiresmail, Sayyid Javad
Forushani, Abbas Rahimi
Bitarafan, Vida

المصدر

Iranian Red Crescent Medical Journal

العدد

المجلد 16، العدد 10 (31 أكتوبر/تشرين الأول 2014)، ص ص. 1-7، 7ص.

الناشر

المستشفى الإيراني

تاريخ النشر

2014-10-31

دولة النشر

الإمارات العربية المتحدة

عدد الصفحات

7

التخصصات الرئيسية

الطب البشري

الموضوعات

الملخص EN

Background : Low plasma concentrations of coenzyme Q10 (CoQ10) have been associated with concentration of lipoproteins and other factors contributing to coronary heart diseases.

Objectives : The present investigation aimed to improve the blood pressure and serum lipoproteins concentration in patients with myocardial infarction (MI) by CoQ10 supplementation.

Patients and Methods : In this randomized double-blinded controlled clinical trial, 52 Iranian patients with hyperlipidemia and MI were recruited to examine the effect of CoQ10 on serum total cholesterol (TC), LDL-C, HDL-C, triglyceride (TG), LDL-C / HDL-C ratio, TC / HDL-C ratio, fibrinogen, systolic blood pressure (SBP) and diastolic blood pressure (DBP).

Individuals were randomly allocated to two groups for receiving either 200 mg / d of CoQ10 or placebo for 12 weeks.

Results : There were not significant differences in serum LDL-C (2.70 ± 0.31 vs.

2.70 ± 0.35 mmol / L), TC (4.47 ± 0.33 vs.

4.93 ± 0.57 mmol / L), TG (2.48 ± 0.12 vs.

2.25 ± 0.69 mmol / L), and fibrinogen (2.08 ± 0.99 vs.

38.7 ± 0.64 mg / dL) between CoQ10 and placebo groups.

After 12 weeks, a significant enhancement in serum HDL-C (1.44 ± 0.18 vs.

1.14 ± 0.18 mmol / L) level was observed between groups after the supplementation (P < 0.001).

A significant reduction of TC, LDL-C, and fibrinogen and a significant increase in HDL-C concentration was observed in CoQ10 group after intervention (P < 0.001).

Our assessment demonstrated statistically significant differences between the two groups in SBP and DBP after intervention (P < 0.001).

ANCOVA also revealed significant differences in the ratio of LDL-C / HDL-C and TC / HDL-C between the two groups (1.89 ± 0.42 vs.

2.39 ± 0.38, P = 0.002 ; and 3.2 ± 0.5 vs.

4.24 ± 0.66, P = 0.01, respectively).

A significant reduction of LDL-C / HDL-C and TC / HDL-C was observed in CoQ10 group (P < 0.001).

Conclusions : Twelve-week supplementation with CoQ10 in patients with hyperlipidemia and MI can improve blood pressure, serum HDL-C as well as LDL-C / HDL-C and TC / HDL-C ratios ; therefore, it might decrease the risk of frequent MI.

نمط استشهاد جمعية علماء النفس الأمريكية (APA)

Muhsini, Muna& Vafa, Muhammad Riza& Hajimiresmail, Sayyid Javad& Zarrati, Mitra& Forushani, Abbas Rahimi& Bitarafan, Vida…[et al.]. 2014. Effects of coenzyme q10 supplementation on serum lipoproteins, plasma fibrinogen, and blood pressure in patients with hyperlipidemia and myocardial infarction. Iranian Red Crescent Medical Journal،Vol. 16, no. 10, pp.1-7.
https://search.emarefa.net/detail/BIM-419639

نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)

Muhsini, Muna…[et al.]. Effects of coenzyme q10 supplementation on serum lipoproteins, plasma fibrinogen, and blood pressure in patients with hyperlipidemia and myocardial infarction. Iranian Red Crescent Medical Journal Vol. 16, no. 10 (Oct. 2014), pp.1-7.
https://search.emarefa.net/detail/BIM-419639

نمط استشهاد الجمعية الطبية الأمريكية (AMA)

Muhsini, Muna& Vafa, Muhammad Riza& Hajimiresmail, Sayyid Javad& Zarrati, Mitra& Forushani, Abbas Rahimi& Bitarafan, Vida…[et al.]. Effects of coenzyme q10 supplementation on serum lipoproteins, plasma fibrinogen, and blood pressure in patients with hyperlipidemia and myocardial infarction. Iranian Red Crescent Medical Journal. 2014. Vol. 16, no. 10, pp.1-7.
https://search.emarefa.net/detail/BIM-419639

نوع البيانات

مقالات

لغة النص

الإنجليزية

الملاحظات

Includes bibliographical references : p. 6-7

رقم السجل

BIM-419639